Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects

NCT06037395 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
154
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celltrion